LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Dovitinib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3885 | 4203 | 0.9251 | 0.9153 |
MCF7 | Dovitinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2707 | 4203 | 0.6441 | 0.5634 |
MCF7 | Dovitinib | 1.11 | uM | LJP5 | 72 | hr | 1209 | 2067 | 4203 | 0.4912 | 0.3450 |
MCF7 | Dovitinib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1690 | 4203 | 0.4021 | 0.2035 |
MCF7 | Dovitinib | 10 | uM | LJP5 | 72 | hr | 1209 | 1654 | 4203 | 0.3937 | 0.1895 |
MCF7 | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 2794 | 4203 | 0.6647 | 0.5926 |
MCF7 | GSK 690693 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 2286 | 4203 | 0.5448 | 0.4261 |
MCF7 | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2009 | 4203 | 0.4779 | 0.3243 |
MCF7 | GSK 690693 | 1.11 | uM | LJP5 | 72 | hr | 1209 | 1923 | 4203 | 0.4582 | 0.2947 |
MCF7 | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1828 | 4203 | 0.4359 | 0.2593 |
MCF7 | GSK 690693 | 10 | uM | LJP5 | 72 | hr | 1209 | 1699 | 4203 | 0.4048 | 0.2084 |
MCF7 | SNS-032 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1200 | 4012 | 0.2993 | -0.0048 |
MCF7 | SNS-032 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 734 | 4012 | 0.1835 | -0.2505 |
MCF7 | SNS-032 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 723 | 4012 | 0.1801 | -0.2581 |
MCF7 | SNS-032 | 1.11 | uM | LJP6 | 72 | hr | 1209 | 720 | 4012 | 0.1798 | -0.2592 |
MCF7 | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 702 | 4012 | 0.1752 | -0.2704 |
MCF7 | SNS-032 | 10 | uM | LJP6 | 72 | hr | 1209 | 694 | 4012 | 0.1730 | -0.2754 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3665 | 4012 | 0.9147 | 0.9003 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3666 | 4012 | 0.9160 | 0.9019 |
MCF7 | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 3723 | 4012 | 0.9287 | 0.9168 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1209 | 2817 | 4012 | 0.7008 | 0.6263 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3086 | 4012 | 0.7711 | 0.7213 |
MCF7 | Afatinib | 10 | uM | LJP6 | 72 | hr | 1209 | 922 | 4012 | 0.2304 | -0.1451 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 1209 | 2379 | 4012 | 0.5937 | 0.4795 |
MCF7 | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 1209 | 2269 | 4012 | 0.5660 | 0.4382 |